☰

Hai Feng, Ph.D. - Publications

Affiliations: 
2011 The Chinese University of Hong Kong, Hong Kong, Hong Kong 
Area:
Molecular Biology, Cell Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Zhang X, Lu X, Shi J, Li Y, Li Y, Tao R, Huang L, Tang Y, Zhu X, Li M, Gao Y, Feng H, Yu Z. Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 126: 155395. PMID 38340578 DOI: 10.1016/j.phymed.2024.155395  0.32
2022 Li Y, Li Y, Zhang X, Duan X, Feng H, Yu Z, Gao Y. A novel association of pyroptosis-related gene signature with the prognosis of hepatocellular carcinoma. Frontiers in Oncology. 12: 986827. PMID 36267972 DOI: 10.3389/fonc.2022.986827  0.322
2022 Li Y, Li Y, Zhang J, Ji L, Li M, Sun X, Feng H, Yu Z, Gao Y. Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 9: 41-56. PMID 35178363 DOI: 10.2147/JHC.S346047  0.303
2021 Jiang Y, Shen X, Fasae MB, Zhi F, Chai L, Ou Y, Feng H, Liu S, Liu Y, Yang S. The Expression and Function of Circadian Rhythm Genes in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity. 2021: 4044606. PMID 34697563 DOI: 10.1155/2021/4044606  0.316
2021 Khan H, Ni Z, Feng H, Xing Y, Wu X, Huang D, Chen L, Niu Y, Shi G. Combination of curcumin with N-n-butyl haloperidol iodide inhibits hepatocellular carcinoma malignant proliferation by downregulating enhancer of zeste homolog 2 (EZH2) - lncRNA H19 to silence Wnt/β-catenin signaling. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 91: 153706. PMID 34517264 DOI: 10.1016/j.phymed.2021.153706  0.313
2020 Yu Z, Feng H, Zhuo Y, Li M, Zhu X, Huang L, Zhang X, Zhou Z, Zheng C, Jiang Y, Le F, Yu DY, Cheng AS, Sun X, Gao Y. Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation. Cellular Oncology (Dordrecht). PMID 32623699 DOI: 10.1007/s13402-020-00546-0  0.325
2020 Khan H, Jia W, Yu Z, Zaib T, Feng J, Jiang Y, Song H, Bai Y, Yang B, Feng H. Emodin succinyl ester inhibits malignant proliferation and migration of hepatocellular carcinoma by suppressing the interaction of AR and EZH2. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 128: 110244. PMID 32464306 DOI: 10.1016/j.biopha.2020.110244  0.356
2018 Song H, Yu Z, Sun X, Feng J, Yu Q, Khan H, Zhu X, Huang L, Li M, Mok MTS, Cheng ASL, Gao Y, Feng H. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling. Ebiomedicine. PMID 30150059 DOI: 10.1016/j.ebiom.2018.08.043  0.361
2018 Yu Z, Feng H, Sun X, Zhuo Y, Li M, Zhou Z, Huang L, Jiang Y, Zhu X, Zhang X, Le F, Zheng C, Cheng AS, Gao Y. Bufalin suppresses hepatocarcinogenesis by targeting β-catenin/TCF signaling via cell cycle-related kinase. Scientific Reports. 8: 3891. PMID 29497076 DOI: 10.1038/s41598-018-22113-2  0.379
2015 Feng H, Yu Z, Tian Y, Lee YY, Li MS, Go MY, Cheung YS, Lai PB, Chan AM, To KF, Chan HL, Sung JJ, Cheng AS. A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients. Journal of Hepatology. 62: 1100-11. PMID 25500144 DOI: 10.1016/J.Jhep.2014.11.040  0.41
2014 Yu Z, Gao YQ, Feng H, Lee YY, Li MS, Tian Y, Go MY, Yu DY, Cheung YS, Lai PB, Yu J, Wong VW, Sung JJ, Chan HL, Cheng AS. Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepatocarcinogenesis. Gut. 63: 1793-804. PMID 24440987 DOI: 10.1136/Gutjnl-2013-305584  0.421
2014 Cheng ASL, Feng H, Yu Z, Lee Y, Li MS, Cheung Y, Lai PBS, Sung JJY. Abstract 4500: An AR-regulated kinase CCRK activates a tumor-initiating circuitry through dual regulation of EZH2 Cancer Research. 74: 4500-4500. DOI: 10.1158/1538-7445.Am2014-4500  0.419
2012 Lau KM, Chan QK, Pang JC, Ma FM, Li KK, Yeung WW, Cheng AS, Feng H, Chung NY, Li HM, Zhou L, Wang Y, Mao Y, Ng HK. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma. Acta Neuropathologica. 123: 553-71. PMID 22249617 DOI: 10.1007/S00401-011-0934-8  0.318
2011 Feng H, Cheng AS, Tsang DP, Li MS, Go MY, Cheung YS, Zhao GJ, Ng SS, Lin MC, Yu J, Lai PB, To KF, Sung JJ. Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis. The Journal of Clinical Investigation. 121: 3159-75. PMID 21747169 DOI: 10.1172/Jci45967  0.459
2011 Cheng AS, Lau SS, Chen Y, Kondo Y, Li MS, Feng H, Ching AK, Cheung KF, Wong HK, Tong JH, Jin H, Choy KW, Yu J, To KF, Wong N, et al. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. Cancer Research. 71: 4028-39. PMID 21512140 DOI: 10.1158/0008-5472.Can-10-3342  0.425
2011 Cheng AS, Feng H, Tsang DP, Li MS, Go MY, Cheung SY, Ng SS, Lin MC, To KF, Yu J, Lai PB, Sung JJ. Abstract 2170: Dissecting the oncogenic function of a novel androgen receptor-dependent direct target, cell cycle-related kinase (CCRK), in hepatocellular carcinoma Cancer Research. 71: 2170-2170. DOI: 10.1158/1538-7445.Am2011-2170  0.466
2010 Yu J, Shen B, Chu ES, Teoh N, Cheung KF, Wu CW, Wang S, Lam CN, Feng H, Zhao J, Cheng AS, To KF, Chan HL, Sung JJ. Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro. Hepatology (Baltimore, Md.). 51: 2008-19. PMID 20512989 DOI: 10.1002/Hep.23550  0.407
2010 Cheng AS, Lau S, Chen Y, Kondo Y, Li M, Feng H, Ching A, Cheung P, Wong K, Jin H, Choy R, Yu J, To KF, Wong N, Huang T, et al. Abstract 4881: Polycomb protein EZH2 activates Wnt/β-catenin signaling to promote hepatocellular carcinoma development Cancer Research. 70: 4881-4881. DOI: 10.1158/1538-7445.Am10-4881  0.393
2010 Feng H, Cheng AS, Go MY, Yu J, Sung JJ. 219 Cell Cycle-Related Kinase is a Novel Direct Effector of Androgen Receptor in Hepatocellular Carcinoma Cell Growth Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)60189-8  0.395
2009 Feng H, Cheng AS, Go MY, Yu J, Sung JJ. W1593 Genome-Wide Analysis of Androgen Receptor Binding in Hepatocellular Carcinoma Cells Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)63218-2  0.355
Show low-probability matches.